An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
2011

Atypical Skin Reaction to Rivastigmine Patch

Sample size: 1 publication Evidence: low

Author Information

Author(s): T. Grieco, M. Rossi, V. Faina, I. De Marco, P. Pigatto, S. Calvieri

Primary Institution: Department of Dermatology, Universitá di Roma “La Sapienza”

Hypothesis

Is there a specific hypersensitivity to the rivastigmine transdermal patch in patients with Alzheimer's dementia?

Conclusion

The patient exhibited a specific hypersensitivity to the rivastigmine patch, confirmed by positive patch tests.

Supporting Evidence

  • The patient developed skin lesions after 15 days of using the rivastigmine patch.
  • Patch tests confirmed hypersensitivity to the rivastigmine patch.
  • Skin lesions fully remitted one month after stopping the patch.

Takeaway

One patient had a bad skin reaction to a patch used for Alzheimer's treatment, showing that some people can be allergic to it.

Methodology

The patient underwent allergological testing with patch tests to confirm hypersensitivity.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

75-year-old male patient with Alzheimer's dementia.

Digital Object Identifier (DOI)

10.1155/2011/752098

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication